# The Impact of a Dexmedetomidine Perfusion on Intraoperative Remifentanil Consumption

> **NCT06684197** · NA · NOT_YET_RECRUITING · sponsor: **Ciusss de L'Est de l'Île de Montréal** · enrollment: 72 (estimated)

## Conditions studied

- Dexmedetomidine
- Total Intravenous Anesthesia
- Remifentanil Consumption
- Remifentanil
- Laparoscopic Abdominal Surgery

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06684197
- **Lead sponsor:** Ciusss de L'Est de l'Île de Montréal
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11
- **Primary completion:** 2025-11
- **Final completion:** 2025-11
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2024-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06684197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06684197, "The Impact of a Dexmedetomidine Perfusion on Intraoperative Remifentanil Consumption". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06684197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*